Press Releases - G1 Therapeutics, Inc.

Press Releases

Date	Title
2/28/24	G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
2/27/24	G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
2/15/24	G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
2/12/24	G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee
1/8/24	G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference
1/3/24	G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
1/2/24	G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)